Abstract
EVIDENCE-BASED ANSWER Phosphodiesterase type 5 (PDE-5) inhibitor therapy is superior to placebo for erectile dysfunction (ED) in patients with and without diabetes. No studies directly compare PDE-5 inhibitors (SOR: A, systematic review and RCT). Testosterone treatment may improve sexual function in patients with diabetes and severe hypogonadism (SOR: C, single RCT).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
